"The Role of Cognitive Control in the Transdiagnostic Conceptualization of Intrusive Thoughts"

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 18, 2018

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions
Obsessive-Compulsive DisorderGeneralized Anxiety DisorderMajor Depressive Disorder
Interventions
BEHAVIORAL

Cognitive Control Tasks and Script Driven Imagery

All participants will receive a structured diagnostic assessment and complete self-report questionnaires about cognitive factors and anxiety/mood symptoms. They then will complete a battery of neuropsychological executive functioning tasks on the computer, each of which measures a different facet of cognitive control (i.e., response inhibition, cognitive flexibility, and attentional control). Finally, they will be guided through a standardized script-driven imagery paradigm that involves generating and listening to an individualized imaginal script associated with a moderately distressing intrusive thought. Self-report and psychophysiological data will be collected during this exercise.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Health Resources in Action, Inc.

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03414619 - "The Role of Cognitive Control in the Transdiagnostic Conceptualization of Intrusive Thoughts" | Biotech Hunter | Biotech Hunter